Render image of BioSpring's new nucleic acid factory in Offenbach, Germany. (Credit: BioSpring)
July 3, 2025 07:30 AM EDT
Manufacturing

Ex­clu­sive: Ger­man CD­MO BioSpring em­barks on €100M+ nu­cle­ic acid fac­to­ry

Anna Brown

News Reporter

Ger­man oligonu­cleotide CD­MO BioSpring is ex­pand­ing its foot­print in its home coun­try, bud­get­ing over €100 mil­lion ($106 mil­lion) to build a new nu­cle­ic acid fac­to­ry …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Now pri­vate, blue­bird bio con­tin­ues lead­er­ship re­vamp; Roche R&D ex­ec an­nounces re­tire­ment

Sage talked to 43 'coun­ter­par­ties' be­fore ink­ing Su­per­nus deal

Num­ber of megarounds drop 38% in first half as biotechs strug­gle against wors­en­ing slump

4DMT lays off staff, reshuf­fles team as it dou­bles down on Phase 3 plans

Struc­ture in part­ner­ing talks for GLP-1 pill as mid-stage read­out nears

Chi­na’s rise splits US biotech in­vestors: Cash in, or counter? 

A service from the Financial Times